Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.

Wang SJ, Bourguignon LY.

Am J Pathol. 2011 Mar;178(3):956-63. doi: 10.1016/j.ajpath.2010.11.077. Review.

2.

Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.

Bourguignon LYW, Earle C, Shiina M.

Int J Mol Sci. 2017 Aug 24;18(9). pii: E1849. doi: 10.3390/ijms18091849. Review.

3.

Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.

Bourguignon LY, Shiina M, Li JJ.

Adv Cancer Res. 2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1. Review.

PMID:
25081533
4.

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Bourguignon LY.

Semin Cancer Biol. 2008 Aug;18(4):251-9. doi: 10.1016/j.semcancer.2008.03.007. Epub 2008 Mar 26. Review.

5.

Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.

Bourguignon LY.

Int J Mol Sci. 2016 Apr 7;17(4):517. doi: 10.3390/ijms17040517. Review.

6.

Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Bourguignon LY.

Am J Pathol. 2014 Jul;184(7):1912-9. doi: 10.1016/j.ajpath.2014.03.010. Epub 2014 May 9. Review.

7.

Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.

Shigeishi H, Higashikawa K, Takechi M.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1629-40. doi: 10.1007/s00432-014-1653-z. Epub 2014 Mar 28. Review.

PMID:
24676428
8.

The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.

Nikitovic D, Kouvidi K, Karamanos NK, Tzanakakis GN.

Biomed Res Int. 2013;2013:929531. doi: 10.1155/2013/929531. Epub 2013 Sep 5. Review.

9.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Uribe P, Gonzalez S.

Pathol Res Pract. 2011 Jun 15;207(6):337-42. doi: 10.1016/j.prp.2011.03.002. Epub 2011 Apr 29. Review.

PMID:
21531084
10.

CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance.

Grass GD, Dai L, Qin Z, Parsons C, Toole BP.

Adv Cancer Res. 2014;123:351-73. doi: 10.1016/B978-0-12-800092-2.00013-7. Review.

PMID:
25081536
11.

Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Chen J, Zhou J, Lu J, Xiong H, Shi X, Gong L.

BMC Cancer. 2014 Jan 13;14:15. doi: 10.1186/1471-2407-14-15. Review.

12.

CD44 and the adhesion of neoplastic cells.

Rudzki Z, Jothy S.

Mol Pathol. 1997 Apr;50(2):57-71. Review.

13.

Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.

Ween MP, Oehler MK, Ricciardelli C.

Int J Mol Sci. 2011 Jan 31;12(2):1009-29. doi: 10.3390/ijms12021009. Review.

14.

CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.

Bourguignon LY.

J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):287-97. Review.

PMID:
11547898
15.
16.

Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.

Sayed SI, Dwivedi RC, Katna R, Garg A, Pathak KA, Nutting CM, Rhys-Evans P, Harrington KJ, Kazi R.

Oral Oncol. 2011 Apr;47(4):237-43. doi: 10.1016/j.oraloncology.2011.02.009. Epub 2011 Mar 5. Review.

PMID:
21382740
17.

Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.

Sato N, Kohi S, Hirata K, Goggins M.

Cancer Sci. 2016 May;107(5):569-75. doi: 10.1111/cas.12913. Epub 2016 Mar 18. Review.

18.

Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.

Karousou E, Misra S, Ghatak S, Dobra K, Götte M, Vigetti D, Passi A, Karamanos NK, Skandalis SS.

Matrix Biol. 2017 May;59:3-22. doi: 10.1016/j.matbio.2016.10.001. Epub 2016 Oct 13. Review.

PMID:
27746219
19.

The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.

Assimakopoulos D, Kolettas E, Patrikakos G, Evangelou A.

Histol Histopathol. 2002 Oct;17(4):1269-81. doi: 10.14670/HH-17.1269. Review.

PMID:
12371152
20.

Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, Ghatak S.

FEBS J. 2011 May;278(9):1429-43. doi: 10.1111/j.1742-4658.2011.08071.x. Epub 2011 Mar 25. Review.

Supplemental Content

Support Center